Liverpool Hospital is located in the South Western Sydney suburb of Liverpool, New South Wales, Australia and is a 50-minute drive from the Sydney CBD. It is the second largest hospital in New South Wales and one of the leading trauma centres in Australia.

There are 960 beds in Liverpool Hospital.

During the past decade, Liverpool Hospital conducted 165 clinical trials. In the 10-year time frame, 165 clinical trials started and 43 clinical trials were completed, i.e. on average, 26.1% percent of trials that started reached the finish line to date. In the past 5 years, 88 clinical trials started and 29 clinical trials were completed. i.e. 33% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liverpool Hospital" #1 sponsor was "Trans Tasman Radiation Oncology Group" with 19 trials, followed by "Celgene" with 10 trials sponsored, "Amgen" with 9 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored and "Pfizer" with 9 trials sponsored. Other sponsors include 173 different institutions and companies that sponsored additional 112 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liverpool Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 15 trials as a collaborator, "University of Sydney" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator and "Abbott" with 3 trials as a collaborator. Other collaborators include 261 different institutions and companies that were collaborators in the rest 207 trials.

According to Clinical.Site data, the most researched conditions in "Liverpool Hospital" are "Breast Cancer" (9 trials), "Ulcerative Colitis" (9 trials), "Prostate Cancer" (8 trials), "Crohn Disease" (7 trials) and "Coronary Artery Disease" (6 trials). Many other conditions were trialed in "Liverpool Hospital" in a lesser frequency.

Most popular intervention types in "Liverpool Hospital" are "Drug" (172 trials), "Other" (31 trials), "Radiation" (24 trials), "Device" (16 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "Radiotherapy" (8 trials), "Azacitidine" (5 trials), "Cisplatin" (5 trials) and "Guselkumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Liverpool Hospital" are 208 trials for "All" genders, 13 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Liverpool Hospital". 1 are not yet recruiting, 66 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 93 completed trials in Liverpool Hospital, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Liverpool Hospital, 16 "Phase 1" clinical trials were conducted, 54 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 29 trials that are defined as “Not Applicable".